RG
ACIU icon

Redmile Group’s AC Immune ACIU Stock Holding History

Redmile Group’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,034,299
Closed -$2.79M – 57
2024
Q4 		$2.79M Sell
1,034,299
-659,868
-39% -$2.06M 0.19% 50
2024
Q3 		$6.4M Sell
1,694,167
-113,537
-6% -$396K 0.38% 45
2024
Q2 		$7.21M Sell
1,807,704
-199,327
-10% -$659K 0.44% 43
2024
Q1 		$5.94M Buy
2,007,031
+7,031
+0.4% +$25.2K 0.22% 68
2023
Q4 		$10M Buy
+2,000,000
New +$6.43M 0.36% 52

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Redmile Group's ACIU Position: Q1 2025 in Review

Redmile Group sold out of AC Immune (ACIU) in Q1 2025, closing a stake of 1,034,299 shares — an estimated $2.79M sold.

Redmile Group first reported a position in ACIU in Q4 2023 and held it in 5 quarters. The position peaked at $10M in Q4 2023. 41 funds tracked by Wall St. Rank hold ACIU as of Q1 2025.

  • Redmile Group reported no remaining AC Immune position as of Q1 2025 after selling out during the quarter.
  • Redmile Group sold 1,034,299 AC Immune shares in Q1 2025, an estimated $2.79M.
  • Redmile Group first reported a position in AC Immune in Q4 2023 and held it in 5 quarters.
  • Redmile Group's AC Immune position peaked at $10M in Q4 2023.
  • 41 funds tracked by Wall St. Rank held AC Immune as of Q1 2025.

Based on Redmile Group's 13F filing for Q1 2025, filed 15 May 2025.